AI Governance in Healthcare
AI governance in healthcare is the structure a hospital or health system uses to control the AI tools involved in care and operations. It decides which tools are allowed, on what evidence, for which patients, under whose ownership, with what human review, and how the organization would know if a tool started to fail. Governance is what turns a purchased model into a monitored clinical service with an owner and an off switch.
The demand for this is not abstract. Health systems now run AI across imaging, clinical decision support, documentation, and revenue cycle, often from a dozen vendors, and accreditors and regulators increasingly expect a program that governs all of it. This article outlines the structure that works in practice. It sits under the AI Governance hub.
What a Healthcare AI Governance Program Contains
- An oversight body. A multidisciplinary committee with authority to approve, condition, or block clinical use, including clinical leadership, informatics, compliance and privacy, security, quality and safety, and legal.
- A model inventory. A current register of every AI tool in use or under evaluation, with owner, version, risk tier, data flows, and monitoring status. See AI Model Inventory.
- A risk-tiering method. A way to classify tools by clinical risk and autonomy so review effort matches consequence.
- Release gates. Explicit criteria a tool must meet before clinical use, and documented approval with conditions.
- A monitoring program. Defined metrics, a review cadence, and escalation rules for after go-live. See Monitoring and Observability.
- Change control. A process for reviewing vendor updates and configuration changes, with local re-testing where needed.
- Policies. Written expectations for procurement, data use, transparency to patients and clinicians, and incident reporting.
The Frameworks Most Programs Use
Local programs are usually assembled from the NIST AI Risk Management Framework for structure, the Coalition for Health AI for health-specific assurance practices, Joint Commission guidance on the responsible use of AI in healthcare, and domain guidance such as the ACR imaging AI practice parameter for radiology. FDA guidance on AI-enabled medical devices governs the regulated subset. The frameworks page compares them.
The Governance Lifecycle
- Intake and inventory registration
- Risk tiering
- Evidence review and local validation for higher-risk tools
- Approval with defined conditions and a monitoring plan
- Deployment with training and override rules
- Monitoring and observability on a set cadence
- Change control for updates
- Decommissioning when a tool no longer performs or is no longer used
Starting Small
A minimum viable program is a current inventory, a named owner and risk tier for each tool, a documented release decision, and a monitoring plan with a review cadence. Most organizations start there, pilot the process on two or three real tools, and expand. A program that tries to be complete before it is operational tends to stall.
Common Failure Modes
- An inventory that is only updated at purchase
- Release approval with no monitoring plan attached
- Monitoring metrics defined after a problem rather than at release
- No named clinical owner, so no one is accountable for drift
- Governance that covers new purchases but ignores AI already embedded in existing platforms
Related AI Medicine Now Topics
- AI Governance
- Clinical AI Governance Framework
- AI Governance Frameworks
- Monitoring and Observability
- Clinical AI Procurement Checklist
- FDA AI Inspection Readiness for Clinical AI Software
Reviewed: August 30, 2026. Next review: November 30, 2026.
Frequently Asked Questions
What is AI governance in healthcare?
AI governance in healthcare is the structure a health system uses to decide which AI tools enter care, on what evidence, under whose ownership, with what human review, and with what ongoing monitoring, from intake through decommissioning.
What is the minimum viable AI governance program?
A current inventory of AI tools in use, a named owner and risk tier for each, a documented release decision, and a monitoring plan with a defined review cadence. Programs typically start there and expand.
Which frameworks do healthcare AI governance programs use?
Most combine the NIST AI Risk Management Framework for structure, the Coalition for Health AI for health-specific assurance, Joint Commission guidance for responsible use, and domain guidance such as the ACR imaging AI practice parameter, with FDA guidance for regulated devices.
Related Reading
Clinical AI Governance Framework
A clinical AI governance framework gives hospitals a way to review, deploy, monitor, and retire AI tools with clear accountability. The goal is not bureaucracy for its own sake, but safer decisions around risk, evidence, privacy, workflow, vendor management, and ongoing oversight.
Clinical AI Procurement Checklist
Use this clinical AI procurement scorecard to flag review gaps before a hospital signs a vendor contract, starts a pilot, or expands a clinical AI tool.
Monitoring Clinical AI After Deployment
Clinical AI monitoring starts after go-live, not before. Health systems need a structured way to watch performance, overrides, workflow burden, safety events, version changes, bias signals, and user trust over time.